The administration of baicalein was observed to induce upregulation of the oncogenic protein p53, resulting in the suppression of the angiogenic gene Smad4 and subsequent inhibition of VEGF formation in CRC cells (Wang et al., 2019). Here, VEGFA is linked to colorectal carcinoma.